Literature DB >> 36246760

Spontaneous closure of patent ductus arteriosus in preterm babies after failed attempts at transcatheter device closure.

Ahmed Deniwar1, Matthew Brown1, Duraisamy Balaguru2.   

Abstract

Transcatheter closure of patent ductus arteriosus (PDA) for preterm infants is increasingly performed after the Food and Drug Administration approval of the Amplatzer Piccolo Occluder device (Abbott Inc., Abbott Park, IL, USA) in the United States. We report three babies in whom transcatheter closure of PDA was unsuccessful; however, the PDA closed spontaneously in 1-5 days after the transcatheter attempt. The PDA remained closed during follow-up at 3 weeks, 10 weeks, and 17 months, respectively. Mechanical stimulation of the PDA by the wire during attempted device closure likely induced the PDA closure. Further studies are needed to evaluate whether this is a useful alternative therapy in this patient population. Copyright:
© 2022 Annals of Pediatric Cardiology.

Entities:  

Keywords:  Cardiac catheterization; duct occluder; low birth weight; patent arterial duct; percutaneous; preterm infants

Year:  2022        PMID: 36246760      PMCID: PMC9564407          DOI: 10.4103/apc.apc_117_21

Source DB:  PubMed          Journal:  Ann Pediatr Cardiol        ISSN: 0974-5149


  6 in total

1.  Treatment and Nontreatment of the Patent Ductus Arteriosus: Identifying Their Roles in Neonatal Morbidity.

Authors:  Ronald I Clyman; Melissa Liebowitz
Journal:  J Pediatr       Date:  2017-07-11       Impact factor: 4.406

2.  Initial clinical experience with the Medtronic Micro Vascular Plug™ in transcatheter occlusion of PDAs in extremely premature infants.

Authors:  Shyam Sathanandam; Henri Justino; B Rush Waller; Wolfgang Radtke; Athar M Qureshi
Journal:  Catheter Cardiovasc Interv       Date:  2016-11-26       Impact factor: 2.692

3.  Ductal spasm during performance of transcatheter ductal occlusion.

Authors:  Sarosh P Batlivala; Andrew C Glatz; Matthew J Gillespie; Yoav Dori; Jonathan J Rome
Journal:  Catheter Cardiovasc Interv       Date:  2013-11-09       Impact factor: 2.692

Review 4.  Patent Ductus Arteriosus of the Preterm Infant.

Authors:  Shannon E G Hamrick; Hannes Sallmon; Allison T Rose; Diego Porras; Elaine L Shelton; Jeff Reese; Georg Hansmann
Journal:  Pediatrics       Date:  2020-11       Impact factor: 7.124

Review 5.  Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-analysis.

Authors:  Souvik Mitra; Ivan D Florez; Maria E Tamayo; Lawrence Mbuagbaw; Thuva Vanniyasingam; Areti Angeliki Veroniki; Adriana M Zea; Yuan Zhang; Behnam Sadeghirad; Lehana Thabane
Journal:  JAMA       Date:  2018-03-27       Impact factor: 56.272

6.  Amplatzer Piccolo Occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients ≥700 grams.

Authors:  Shyam K Sathanandam; Dan Gutfinger; Laura O'Brien; Thomas J Forbes; Matthew J Gillespie; Darren P Berman; Aimee K Armstrong; Shabana Shahanavaz; Thomas K Jones; Brian H Morray; Toby A Rockefeller; Henri Justino; David G Nykanen; Evan M Zahn
Journal:  Catheter Cardiovasc Interv       Date:  2020-05-20       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.